← Back to Search

Behavioural Intervention

Exoskeleton-Assisted Movement for Stroke

N/A

Recruiting

Led By Jose L Pons, Ph.D

Research Sponsored by Shirley Ryan AbilityLab

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No history of a brain and/or skull lesion

Age from 18 to 80 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for experiment b, change between baseline and through participant completion, an average of 3 months.

Awards & highlights

Study Summary

This trial will test whether the decoder can control the exoskeleton in real-time based on HD-EMG recordings from the participant's muscles with the aim of providing functional assistance.

Who is the study for?

This trial is for adults aged 18-80 with normal movement in their limbs, no brain/skull lesions, correctable hearing and vision. It includes stroke survivors who had a unilateral, supratentorial stroke over 6 months ago without other neurological disorders.Check my eligibility

What is being tested?

The study tests a new controller for exoskeletons that uses muscle signals to predict movements. Participants will perform various muscle contractions and activities while wearing an exoskeleton that's guided by this technology.See study design

What are the potential side effects?

Since the intervention involves physical activity with an exoskeleton based on muscle signals, potential side effects may include muscle fatigue or discomfort from the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never had a brain or skull lesion.

Select...

I am between 18 and 80 years old.

Select...

My hearing and vision are normal or corrected to normal.

Select...

I do not have any conditions that cause unusual movements in my arms or legs.

Select...

I do not have any neurological disorders.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for experiment b, change between baseline and through participant completion, an average of 3 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for experiment b, change between baseline and through participant completion, an average of 3 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and for experiment b, change between baseline and through participant completion, an average of 3 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 10WMT

Change in 6MWT

Change in Berg Balance Scale

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Healthy ParticipantsExperimental Treatment5 Interventions

The investigators will look at muscle activity of healthy participants from eight lower limb muscles during functional tasks (e.g. single-joint movement, walking, squatting, cycling).

Group II: Clinical ParticipantsExperimental Treatment5 Interventions

The investigators will look at muscle activity of participants post-stroke from eight lower limb muscles during functional tasks (e.g. single-joint movement, walking, squatting, cycling).

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor

194 Previous Clinical Trials

16,832 Total Patients Enrolled

70 Trials studying Stroke

8,265 Patients Enrolled for Stroke

Jose L Pons, Ph.DPrincipal InvestigatorShirley Ryan AbilityLab

1 Previous Clinical Trials

1 Total Patients Enrolled

Media Library

Real-time Neuromuscular Control of Exoskeletons (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04661891 — N/A

Stroke Research Study Groups: Healthy Participants, Clinical Participants

Stroke Clinical Trial 2023: Real-time Neuromuscular Control of Exoskeletons Highlights & Side Effects. Trial Name: NCT04661891 — N/A

Real-time Neuromuscular Control of Exoskeletons (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04661891 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research involve participants of advanced age?

"This clinical trial is recruiting individuals between the ages of 18 and 80."

Answered by AI

How many participants are being monitored in this scientific exploration?

"Affirmative. Clinicaltrials.gov data affirms that this clinical trial is actively accepting applicants; it was initially posted on May 5th 2021 and modified as recently as July 13th 2022. The study has a requirement of 80 participants at 1 facility."

Answered by AI

Does this medical experiment have open enrollment?

"The latest update from clinicaltrials.gov confirms that this trial is actively trying to recruit participants. It was first announced on May 5th 2021, and the post has been updated as recently as July 13th 2022."

Answered by AI

What criteria must be met to qualify for enrollment in this research trial?

"Patients between 18 and 80 years old who have suffered a stroke may qualify for this medical study. The trial aims to recruit around 80 participants in total."

Answered by AI

Who else is applying?

What state do they live in?

Illinois

What site did they apply to?

Shirley Ryan AbilityLab

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

What questions have other patients asked about this trial?

Unable to read focus of trial study. Are there certain medical and/or natural pharmaceutical medications involved? What other types of treatment will be tested? Neurostimulation?

PatientReceived 2+ prior treatments

Recent research and studies

clinicaltrials.govStudy

Real-time Neuromuscular Control of Exoskeletons

Jose Pons 2021. "Real-time Neuromuscular Control of Exoskeletons". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04661891.

All > Stroke